Xylem Inc (XYL)
Official siteINDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE
Market Cap: $21.60B
Last updated: Nov 17, 2026 at 11:06 AM ET
Xylem Inc (XYL) Financials: Revenue, Profit and Cash Flow
Xylem reported revenue of $9.04B for the fiscal year ended Dec 31, 2025, up 5.5% from the year before. That year, net income was $950.00M with a net margin of 10.5%, operating cash flow was $1.24B and free cash flow was $910.00M. The quarter ended Sep 30, 2026 had revenue of $2.20B and net income of $288.00M.
Revenue and Margins
The operating margin was 13.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $3.77B, a compound annual rate of 10.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $9.04B | +5.5% | 38.5% | 13.5% | 10.5% |
| Dec 2024 | $8.56B | +16.3% | 37.5% | 11.8% | 10.4% |
| Dec 2023 | $7.36B | +33.4% | 36.9% | 8.9% | 8.3% |
| Dec 2022 | $5.52B | +6.3% | 37.7% | 11.3% | 6.4% |
| Dec 2021 | $5.20B | +6.5% | 38.0% | 11.3% | 8.2% |
| Dec 2020 | $4.88B | -7.1% | 37.5% | 7.5% | 5.2% |
| Dec 2019 | $5.25B | +0.8% | 39.0% | 9.3% | 7.6% |
| Dec 2018 | $5.21B | +10.6% | 38.9% | 12.6% | 10.5% |
| Dec 2017 | $4.71B | +24.8% | 39.2% | 11.7% | 7.0% |
| Dec 2016 | $3.77B | N/A | 38.8% | 10.8% | 6.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 6.7% from the year before. In the quarter ended Sep 2026, net income rose 27.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.04B | $8.56B | $7.36B | $5.52B | $5.20B | $4.88B | $5.25B | $5.21B | $4.71B | $3.77B |
| Cost of revenue | $5.56B | $5.35B | $4.65B | $3.44B | $3.22B | $3.05B | $3.20B | $3.18B | $2.86B | $2.31B |
| Gross profit | $3.48B | $3.21B | $2.72B | $2.08B | $1.98B | $1.83B | $2.05B | $2.03B | $1.85B | $1.46B |
| Research and development | $226.00M | $230.00M | $232.00M | $206.00M | $204.00M | $187.00M | $191.00M | $189.00M | $181.00M | $110.00M |
| Operating income | $1.22B | $1.01B | $652.00M | $622.00M | $585.00M | $367.00M | $486.00M | $654.00M | $552.00M | $408.00M |
| Net income | $950.00M | $890.00M | $609.00M | $355.00M | $427.00M | $254.00M | $401.00M | $549.00M | $330.00M | $260.00M |
| EBITDA | $1.78B | $1.54B | $1.12B | $726.00M | $832.00M | $613.00M | $740.00M | $928.00M | $782.00M | $561.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.20B | $2.34B | $2.13B | $2.40B | $2.27B | $2.30B | $2.07B | $2.26B | $2.10B | $2.17B | $2.03B | $2.12B |
| Gross profit | $907.00M | $963.00M | $803.00M | $932.00M | $883.00M | $892.00M | $768.00M | $857.00M | $784.00M | $819.00M | $752.00M | $756.00M |
| Operating income | $385.00M | $390.00M | $244.00M | $353.00M | $334.00M | $305.00M | $231.00M | $267.00M | $280.00M | $253.00M | $209.00M | $211.00M |
| Net income | $288.00M | $261.00M | $189.00M | $333.00M | $226.00M | $224.00M | $167.00M | $326.00M | $217.00M | $194.00M | $153.00M | $266.00M |
Balance Sheet
As of Dec 2025, total debt of $1.94B exceeded cash and equivalents by $463.00M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.63B | $16.49B | $16.11B | $7.95B | $8.28B | $8.75B | $7.71B | $7.22B | $6.86B | $6.47B |
| Current assets | $4.64B | $4.10B | $3.88B | $3.01B | $3.16B | $3.52B | $2.45B | $2.09B | $2.07B | $1.84B |
| Cash and equivalents | $1.48B | $1.12B | $1.02B | $944.00M | $1.35B | $1.88B | $724.00M | $296.00M | $414.00M | $308.00M |
| Total liabilities | $5.88B | $5.61B | $5.94B | $4.45B | $5.05B | $5.77B | $4.74B | $4.44B | $4.34B | $4.27B |
| Short-term debt | $534.00M | $38.00M | $16.00M | $0 | $69.00M | $600.00M | $276.00M | $257.00M | $0 | $260.00M |
| Long-term debt | $1.41B | $1.98B | $2.27B | $1.88B | $2.44B | $2.48B | $2.04B | $2.05B | $2.20B | $2.11B |
| Shareholder equity | $11.48B | $10.64B | $10.17B | $3.49B | $3.22B | $2.97B | $2.96B | $2.77B | $2.50B | $2.19B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.33B | $17.34B | $16.95B | $17.63B | $17.30B | $17.19B | $16.56B | $16.49B | $16.05B | $15.77B | $15.92B | $16.11B |
| Total liabilities | $6.82B | $6.68B | $5.72B | $5.88B | $5.85B | $5.88B | $5.50B | $5.62B | $5.45B | $5.42B | $5.72B | $5.94B |
| Cash and equivalents | $708.00M | $1.28B | $808.00M | $1.48B | $1.19B | $1.17B | $1.06B | $1.12B | $989.00M | $815.00M | $947.00M | $1.02B |
| Shareholder equity | $10.27B | $10.42B | $10.97B | $11.48B | $11.21B | $11.07B | $10.82B | $10.64B | $10.59B | $10.34B | $10.20B | $10.17B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 73.4% of operating cash flow. Dividends and share repurchases together came to 44.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.24B | $1.26B | $837.00M | $596.00M | $538.00M | $824.00M | $839.00M | $586.00M | $686.00M | $497.00M |
| Capital expenditures | $331.00M | $321.00M | $271.00M | $208.00M | $208.00M | $183.00M | $226.00M | $237.00M | $170.00M | $124.00M |
| Free cash flow | $910.00M | $942.00M | $566.00M | $388.00M | $330.00M | $641.00M | $613.00M | $349.00M | $516.00M | $373.00M |
| Dividends paid | $391.00M | $350.00M | $299.00M | $217.00M | $203.00M | $188.00M | $174.00M | $152.00M | $130.00M | $112.00M |
| Share repurchases | $15.00M | $20.00M | $25.00M | $52.00M | $68.00M | $61.00M | $40.00M | $59.00M | $25.00M | $4.00M |
| Investing cash flow | -$471.00M | -$482.00M | -$628.00M | -$191.00M | -$183.00M | -$169.00M | -$231.00M | -$643.00M | -$181.00M | -$1.89B |
| Financing cash flow | -$501.00M | -$615.00M | -$157.00M | -$790.00M | -$855.00M | $473.00M | -$177.00M | -$40.00M | -$421.00M | $1.03B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $331.00M | $290.00M | $108.00M | $543.00M | $360.00M | $305.00M | $33.00M | $575.00M | $311.00M | $288.00M | $89.00M | $455.00M |
| Capital expenditures | $89.00M | $89.00M | $90.00M | $83.00M | $79.00M | $98.00M | $71.00M | $100.00M | $74.00M | $73.00M | $74.00M | $94.00M |
| Free cash flow | $242.00M | $201.00M | $18.00M | $460.00M | $281.00M | $207.00M | -$38.00M | $475.00M | $237.00M | $215.00M | $15.00M | $361.00M |
Frequently Asked Questions About XYL
What is Xylem's annual revenue?
Xylem reported revenue of $9.04B for the fiscal year ended Dec 31, 2025.
How fast is Xylem's revenue growing?
Revenue was up 5.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 17.8%.
Is Xylem profitable?
Yes. Xylem reported net income of $950.00M for the fiscal year ended Dec 31, 2025, with a net margin of 10.5%.
How much free cash flow does XYL generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.24B minus capital expenditures of $331.00M produced free cash flow of $910.00M.
How much debt does Xylem have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.41B, short-term debt of $534.00M and cash and equivalents of $1.48B.
XYL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts